News
-
-
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates
Heidelberg Pharma and Huadong Medicine sign new collaboration agreement to jointly develop Antibody Drug Conjugates, expanding pipeline with innovative products -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates
Heidelberg Pharma and Huadong Medicine sign a new collaboration agreement to jointly develop new Antibody Drug Conjugates, broadening their existing partnership and combining proprietary technologies -
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: REPLOID Group AG plans to increase free float and prepares transition to the prime market segment of the Vienna Stock Exchange
REPLOID Group AG plans to increase free float and transition to prime market segment of Vienna Stock Exchange in Summer 2027, boosting liquidity through capital increases and convertible bonds -
-
COMMUNIQUÉ DE PRESSE
MTG-I2 successfully launched: Europe’s new weather satellite constellation is now complete
Europe's new weather satellite constellation, MTG-I2, successfully launched completing the Meteosat Third Generation constellation. OHB's key role in developing the MTG fleet guarantees high-quality data for weather forecasting and environmental monitoring
![Logo de [UNKNOWN]](https://logos.symex.be/img/.jpg)
